Beit Jala Pharmaceutical Company (PEX:BJP)

Revenue by Segment

Financials in millions JOD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceuticals	12.78M	9.66M	9.61M	10.77M	9.76M
Pharmaceuticals Growth	32.28%	0.54%	-10.73%	10.37%	12.26%
Total	12.78M	9.66M	9.61M	10.77M	9.76M
Total Growth	32.28%	0.54%	-10.73%	10.37%	12.26%

Revenue by Geography

Financials in millions JOD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Palestinian Authority	8.72M	6.41M	7.17M	8.39M	7.99M
Palestinian Authority Growth	36.08%	-10.62%	-14.57%	5.05%	15.90%
Export	4.06M	3.25M	2.44M	2.37M	1.76M
Export Growth	24.79%	33.34%	2.85%	34.51%	-1.71%
Total	12.78M	9.66M	9.61M	10.77M	9.76M
Total Growth	32.28%	0.54%	-10.73%	10.37%	12.26%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 16, 2026

Data Sources Report a data error